Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders

Obesity is a major contributor to metabolic and cardiovascular disease. Although senescent cells have been shown to accumulate in adipose tissue, the role of senescence in obesity-induced metabolic disorders and in cardiac dysfunction is not yet clear; therefore, the therapeutic potential of managin...

Full description

Saved in:
Bibliographic Details
Main Authors: Tábatha de Oliveira Silva, Guilherme Lunardon, Caroline A. Lino, Amanda de Almeida Silva, Shiju Zhang, Maria Cláudia Costa Irigoyen, Yao Wei Lu, John D. Mably, Maria Luiza M. Barreto-Chaves, Da-Zhi Wang, Gabriela P. Diniz
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Molecular Metabolism
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877824001960
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553850309279744
author Tábatha de Oliveira Silva
Guilherme Lunardon
Caroline A. Lino
Amanda de Almeida Silva
Shiju Zhang
Maria Cláudia Costa Irigoyen
Yao Wei Lu
John D. Mably
Maria Luiza M. Barreto-Chaves
Da-Zhi Wang
Gabriela P. Diniz
author_facet Tábatha de Oliveira Silva
Guilherme Lunardon
Caroline A. Lino
Amanda de Almeida Silva
Shiju Zhang
Maria Cláudia Costa Irigoyen
Yao Wei Lu
John D. Mably
Maria Luiza M. Barreto-Chaves
Da-Zhi Wang
Gabriela P. Diniz
author_sort Tábatha de Oliveira Silva
collection DOAJ
description Obesity is a major contributor to metabolic and cardiovascular disease. Although senescent cells have been shown to accumulate in adipose tissue, the role of senescence in obesity-induced metabolic disorders and in cardiac dysfunction is not yet clear; therefore, the therapeutic potential of managing senescence in obesity-related metabolic and cardiac disorders remains to be fully defined. Objective: We investigated the beneficial effects of a senolytic cocktail (dasatinib and quercetin) on senescence and its influence on obesity-related parameters. Methods and Results: We found that the increase in body weight and adiposity, glucose intolerance, insulin resistance, dyslipidemia, hyperleptinemia, and hepatic disorders which were induced by an obesogenic diet were alleviated by senolytic cocktail treatment in mice. Treatment with senolytic compounds eliminated senescent cells, counteracting the activation of the senescence program and DNA damage in white adipose tissue (WAT) observed with an obesogenic diet. Moreover, the senolytic cocktail prevented the brown adipose tissue (BAT) whitening and increased the expression of the thermogenic gene profile in BAT and pWAT. In the hearts of obese mice, senolytic combination abolished myocardial maladaptation, reducing the senescence-associated secretory phenotype (SASP) and DNA damage, repressing cardiac hypertrophy, and improving diastolic dysfunction. Additionally, we showed that treatment with the senolytic cocktail corrected gene expression programs associated with fatty acid metabolism, oxidative phosphorylation, the P53 pathway, and DNA repair, which were all downregulated in obese mice. Conclusions: Collectively, these data suggest that a senolytic cocktail can prevent the activation of the senescence program in the heart and WAT and activate the thermogenic program in BAT. Our results suggest that targeting senescent cells may be a novel therapeutic strategy for alleviating obesity-related metabolic and cardiac disorders.
format Article
id doaj-art-d498681e12994eee98dc1c59881f0ffa
institution Kabale University
issn 2212-8778
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Molecular Metabolism
spelling doaj-art-d498681e12994eee98dc1c59881f0ffa2025-01-09T06:13:52ZengElsevierMolecular Metabolism2212-87782025-01-0191102065Senescent cell depletion alleviates obesity-related metabolic and cardiac disordersTábatha de Oliveira Silva0Guilherme Lunardon1Caroline A. Lino2Amanda de Almeida Silva3Shiju Zhang4Maria Cláudia Costa Irigoyen5Yao Wei Lu6John D. Mably7Maria Luiza M. Barreto-Chaves8Da-Zhi Wang9Gabriela P. Diniz10Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil; Center for Regenerative Medicine, USF Health Heart Institute, University of South Florida, Tampa, FL, USADepartment of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, SP, BrazilDepartment of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, SP, BrazilHypertension Unit, Heart Institute (InCor), School of Medicine, University of Sao Paulo, Sao Paulo, SP, BrazilCenter for Regenerative Medicine, USF Health Heart Institute, University of South Florida, Tampa, FL, USAHypertension Unit, Heart Institute (InCor), School of Medicine, University of Sao Paulo, Sao Paulo, SP, BrazilVascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Department of Medicine, and Hastings Center for Pulmonary Research, Keck School of Medicine, University of Southern California, Los Angeles, CA, USACenter for Regenerative Medicine, USF Health Heart Institute, University of South Florida, Tampa, FL, USADepartment of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, SP, BrazilCenter for Regenerative Medicine, USF Health Heart Institute, University of South Florida, Tampa, FL, USADepartment of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil; Center for Regenerative Medicine, USF Health Heart Institute, University of South Florida, Tampa, FL, USA; Corresponding author. Center for Regenerative Medicine, University of South Florida Health Heart Institute, University of South Florida, 560 Channelside Dr., MDD 715, Tampa, FL 33602, USA.Obesity is a major contributor to metabolic and cardiovascular disease. Although senescent cells have been shown to accumulate in adipose tissue, the role of senescence in obesity-induced metabolic disorders and in cardiac dysfunction is not yet clear; therefore, the therapeutic potential of managing senescence in obesity-related metabolic and cardiac disorders remains to be fully defined. Objective: We investigated the beneficial effects of a senolytic cocktail (dasatinib and quercetin) on senescence and its influence on obesity-related parameters. Methods and Results: We found that the increase in body weight and adiposity, glucose intolerance, insulin resistance, dyslipidemia, hyperleptinemia, and hepatic disorders which were induced by an obesogenic diet were alleviated by senolytic cocktail treatment in mice. Treatment with senolytic compounds eliminated senescent cells, counteracting the activation of the senescence program and DNA damage in white adipose tissue (WAT) observed with an obesogenic diet. Moreover, the senolytic cocktail prevented the brown adipose tissue (BAT) whitening and increased the expression of the thermogenic gene profile in BAT and pWAT. In the hearts of obese mice, senolytic combination abolished myocardial maladaptation, reducing the senescence-associated secretory phenotype (SASP) and DNA damage, repressing cardiac hypertrophy, and improving diastolic dysfunction. Additionally, we showed that treatment with the senolytic cocktail corrected gene expression programs associated with fatty acid metabolism, oxidative phosphorylation, the P53 pathway, and DNA repair, which were all downregulated in obese mice. Conclusions: Collectively, these data suggest that a senolytic cocktail can prevent the activation of the senescence program in the heart and WAT and activate the thermogenic program in BAT. Our results suggest that targeting senescent cells may be a novel therapeutic strategy for alleviating obesity-related metabolic and cardiac disorders.http://www.sciencedirect.com/science/article/pii/S2212877824001960ObesityCellular senescencebrown adipose tissueMetabolic dysfunctionCardiac dysfunction
spellingShingle Tábatha de Oliveira Silva
Guilherme Lunardon
Caroline A. Lino
Amanda de Almeida Silva
Shiju Zhang
Maria Cláudia Costa Irigoyen
Yao Wei Lu
John D. Mably
Maria Luiza M. Barreto-Chaves
Da-Zhi Wang
Gabriela P. Diniz
Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders
Molecular Metabolism
Obesity
Cellular senescence
brown adipose tissue
Metabolic dysfunction
Cardiac dysfunction
title Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders
title_full Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders
title_fullStr Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders
title_full_unstemmed Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders
title_short Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders
title_sort senescent cell depletion alleviates obesity related metabolic and cardiac disorders
topic Obesity
Cellular senescence
brown adipose tissue
Metabolic dysfunction
Cardiac dysfunction
url http://www.sciencedirect.com/science/article/pii/S2212877824001960
work_keys_str_mv AT tabathadeoliveirasilva senescentcelldepletionalleviatesobesityrelatedmetabolicandcardiacdisorders
AT guilhermelunardon senescentcelldepletionalleviatesobesityrelatedmetabolicandcardiacdisorders
AT carolinealino senescentcelldepletionalleviatesobesityrelatedmetabolicandcardiacdisorders
AT amandadealmeidasilva senescentcelldepletionalleviatesobesityrelatedmetabolicandcardiacdisorders
AT shijuzhang senescentcelldepletionalleviatesobesityrelatedmetabolicandcardiacdisorders
AT mariaclaudiacostairigoyen senescentcelldepletionalleviatesobesityrelatedmetabolicandcardiacdisorders
AT yaoweilu senescentcelldepletionalleviatesobesityrelatedmetabolicandcardiacdisorders
AT johndmably senescentcelldepletionalleviatesobesityrelatedmetabolicandcardiacdisorders
AT marialuizambarretochaves senescentcelldepletionalleviatesobesityrelatedmetabolicandcardiacdisorders
AT dazhiwang senescentcelldepletionalleviatesobesityrelatedmetabolicandcardiacdisorders
AT gabrielapdiniz senescentcelldepletionalleviatesobesityrelatedmetabolicandcardiacdisorders